Additionally, the fraction of intratumoral CD8+ and CD4+ T cells was higher in CTX + ICB + CXB-treated mice compared with CTX + ICB- or control-treated mice, with no clear difference in their number per gram of tumor across any of the groups (Fig. 6g, h). The gene discussed is CD4; the disease is neoplasm.